The Wall Street investment bank polled its analysts about the probability of M & A activity of the companies under its research coverage.
Analysts were tasked with assigning a "1" ranking to those possible targets if the probability was 30%-50% of M & A activity in the next 12 months.
In a tight credit environment and amid concern about a looming recession, M & A activity saw a sluggish first half of the year.
The market is expected to open up as interest rates stop rising, and the stocks on Goldman's list could have the potential to be taken over once credit becomes more available.
Health care stocks Maravai LifeSciences , Quanterix Corp ., Enhabit also have a relatively high likelihood of being M & A targets in the next 12 months, according to Goldman analysts.
Persons:
Goldman Sachs, Bud, Enhabit, Goldman
Organizations:
Companies, P Global Market Intelligence, Molson Coors Beverage, Bellring Brands, Foods, Citi, Molson Coors, Quanterix Corp